Breaking the ice: urine proteomics of medullary sponge kidney disease.
Level V
Where this comes from
- Record sourced from PubMed, PMID 28087010.
- Also identified by DOI 10.1016/j.kint.2016.10.032.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Urinary proteomics is a promising tool for biomarker investigation, particularly in complex kidney diseases. Fabris and colleagues report that urinary laminin subunit alpha-2 is a potential diagnostic marker of medullary sponge kidney (MSK) disease by using a label-free quantitative proteomics platform and a clinically compatible enzyme-linked immunosorbent assay. The neglected issue of stone pathogenesis was also evidenced. This commentary discusses several considerations in biomarker validation, and how urinary proteomics breaks new ground in MSK research.
Medical subject headings
- Medullary Sponge Kidney
- Proteomics